The American journal of cardiology

publication venue for

Passage of microbubbles associated with intravenous infusion into the systemic circulation in cyanotic congenital heart disease: documentation by transesophageal echocardiography. 1987
Prolonged survival (62 years) with single ventricle. 1983
Mortality Associated With Proportionality of Secondary Mitral Regurgitation After Transcatheter Mitral Valve Repair: North American Mitraclip for Functional Mitral Regurgitation Registry. 2023
Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis).. 207. 2023
Trends in the Incidence of Cardiogenic Shock, and Utilization of Mechanical Circulatory Support in Myocarditis: Insights from the National Inpatient Sample 2016 to 2019.. 205. 2023
Dispelling the Saddle Pulmonary Embolism Myth (from a Comparison of Saddle Versus Non-Saddle Pulmonary Embolism).. 201. 2023
Suboptimal Cardiology Follow-Up Among Patients With and Without Cancer Hospitalized for Heart Failure. 2023
Patient Awareness of Their Heart Failure Diagnosis and Its Implications for Epidemiologic Studies and Clinical Care.. 195. 2023
Physician Perspectives on the Use of Beta Blockers in Heart Failure With Preserved Ejection Fraction.. 193. 2023
Developing a Parsimonious Frailty Index for Older, Multimorbid Adults With Heart Failure Using Machine Learning.. 190. 2022
Relation of Left Ventricular Hypertrophy Subtype to Long-Term Mortality in Those With Subclinical Cardiovascular Disease (from the Multiethnic Study of Atherosclerosis [MESA]). 2022
Beta-Blocker Use in Hypertension and Heart Failure (A Secondary Analysis of the Systolic Blood Pressure Intervention Trial).. 165. 2021
Cardiac and Obstetric Outcomes Associated With Mitral Valve Prolapse.. 162. 2021
Characteristics and Outcomes of Patients Admitted With Type 2 Myocardial Infarction.. 157. 2021
Sex-Based Disparities in Outcomes With Abdominal Aortic Aneurysms.. 155. 2021
Relation between Modified Body Mass Index and Adverse Outcomes after Aortic Valve Implantation.. 153. 2021
Frailty and Post-hospitalization Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.. 148. 2021
Frequency of Atrial Arrhythmia in Hospitalized Patients With COVID-19.. 147. 2021
In-Hospital Outcomes and Trends of Endovascular Intervention vs Surgical Revascularization in Octogenarians With Peripheral Artery Disease.. 145. 2021
Relation of Bariatric Surgery to Inpatient Cardiovascular Outcomes (from the National Inpatient Sample).. 144. 2020
Usefulness of Elevated Troponin to Predict Death in Patients With COVID-19 and Myocardial Injury.. 138. 2020
Impact of Frailty on Mortality, Readmissions, and Resource Utilization After TAVI.. 127. 2020
Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status.. 127. 2020
Relation of Low Serum Magnesium to Mortality and Cardiac Allograft Vasculopathy Following Heart Transplantation.. 125. 2020
Relation of a Simple Cardiac Co-Morbidity Count and Cardiovascular Readmission After a Heart Failure Hospitalization.. 125. 2020
Impact Of Cirrhosis On 90-Day Outcomes After Percutaneous Coronary Intervention (from A Nationwide Database).. 125. 2020
Novel Anatomic Predictors of New Persistent Left Bundle Branch Block After Evolut Transcatheter Aortic Valve Implantation.. 125. 2020
Comparison of Holter With Zio Patch Electrocardiography Monitoring in Children.. 125. 2019
Comparison of Age (<75 Years Vs ≥75 Years) and Platelet Reactivity to the Risk of Thrombotic and Bleeding Events After Successful Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).. 125. 2019
Incidence and Prognostic Impact of Atrial Fibrillation After Discharge Following Revascularization for Significant Left Main Coronary Artery Narrowing.. 125. 2019
Utility of Computed Tomography to Predict Ventricular Arrhythmias in Patients With Nonischemic Cardiomyopathy Receiving Cardiac Resynchronization Therapy.. 125. 2019
Risk Reclassification With Coronary Computed Tomography Angiography-Visualized Nonobstructive Coronary Artery Disease According to 2018 American College of Cardiology/American Heart Association Cholesterol Guidelines (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes : An International Multicenter Registry [CONFIRM]).. 124. 2019
Relationship Between Stent Diameter, Platelet Reactivity, and Thrombotic Events After Percutaneous Coronary Artery Revascularization.. 124. 2019
Association Between Hypertension, Platelet Reactivity, and the Risk of Adverse Events After Percutaneous Coronary Intervention (From the ADAPT-DES Study).. 124. 2019
Comparison of Effectiveness of Alcohol Septal Ablation Versus Ventricular Septal Myectomy on Acute Care Use for Cardiovascular Disease in Patients With Hypertrophic Cardiomyopathy.. 124. 2019
Relation of Hospital Volume With In-Hospital and 90-Day Outcomes After Transcatheter Mitral Valve Repair Using MitraClip.. 124. 2019
Medication-Taking Behaviors and Perceptions Among Adults With Heart Failure (from the REasons for Geographic And Racial Differences in Stroke Study).. 123. 2019
Usefulness of Atherectomy in Chronic Total Occlusion Interventions (from the PROGRESS-CTO Registry).. 123. 2019
The Predictive Value of Coronary Artery Calcium Scoring for Major Adverse Cardiac Events According to Renal Function (from the Coronary Computed Tomography Angiography Evaluation for Clinical Outcomes: An International Multicenter [CONFIRM] Registry).. 123. 2019
Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts.. 123. 2019
Impact of Point-of-Care Platelet Function Testing Among Patients With and Without Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents (from the ADAPT-DES Study).. 123. 2018
Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary Syndrome.. 123. 2018
Impact of On-Site Surgical Backup on Periprocedural Outcomes of Primary Percutaneous Interventions in Patients Presenting With ST-Segment Elevation Myocardial Infarction (From the ORPKI Polish National Registry).. 122. 2018
Willingness to be Reinitiated on a Statin (from the REasons for Geographic and Racial Differences in Stroke Study).. 122. 2018
In-hospital Outcomes of Attempting More Than One Chronic Total Coronary Occlusion Through Percutaneous Intervention During the Same Procedure.. 122. 2018
Multimodality Assessment of Right Ventricular Strain in Patients With Acute Pulmonary Embolism.. 122. 2018
Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study).. 122. 2018
Usefulness of Tricuspid Annular Diameter to Predict Late Right Sided Heart Failure in Patients With Left Ventricular Assist Device.. 122. 2018
Usefulness of High-Dose Oral Flecainide for Termination of Recent-Onset Atrial Fibrillation in Children.. 121. 2018
Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome.. 121. 2018
Discharge Processes and 30-Day Readmission Rates of Patients Hospitalized for Heart Failure on General Medicine and Cardiology Services.. 121. 2018
Comparison of Outcomes for Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in Low-Volume and High-Volume Centers and by Low-Volume and High-Volume Surgeons.. 121. 2017
Patient Selection Process for the Harmony Transcatheter Pulmonary Valve Early Feasibility Study.. 120. 2017
Incidence, Treatment, and Outcomes of Coronary Perforation During Chronic Total Occlusion Percutaneous Coronary Intervention.. 120. 2017
Cangrelor Versus Clopidogrel on a Background of Unfractionated Heparin (from CHAMPION PHOENIX).. 120. 2017
Aortic Dilatation Associated With Bicuspid Aortic Valve: Relation to Sex, Hemodynamics, and Valve Morphology (the National Heart Lung and Blood Institute-Sponsored National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions).. 120. 2017
Impact of Asymmetric Dimethylarginine on Coronary Physiology Early After Heart Transplantation.. 120. 2017
Quantifying Ischemic Risk After Percutaneous Coronary Intervention Attributable to High Platelet Reactivity on Clopidogrel (From the Assessment of Dual Antiplatelet Therapy with Drug-Eluting Stents Study).. 120. 2017
Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study).. 120. 2017
In-Hospital Cardiovascular Complications After Pancreas Transplantation in the United States from 2003 to 2012.. 120. 2017
Impact of Calcium on Chronic Total Occlusion Percutaneous Coronary Interventions.. 120. 2017
Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).. 119. 2017
Comparison of QRS Duration and Associated Cardiovascular Events in American Indian Men Versus Women (The Strong Heart Study).. 119. 2017
Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).. 119. 2017
Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).. 119. 2017
Influence of Left Ventricular Stroke Volume on Incident Heart Failure in a Population With Preserved Ejection Fraction (from the Strong Heart Study).. 119. 2017
Chronobiology of Acute Aortic Dissection in the Marfan Syndrome (from the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions and the International Registry of Acute Aortic Dissection).. 119. 2016
Causes and Predictors of Death in Patients With Coronary Heart Disease (from the Heart and Soul Study).. 119. 2016
Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT).. 118. 2016
Effect of Smoking on Infarct Size and Major Adverse Cardiac Events in Patients With Large Anterior ST-Elevation Myocardial Infarction (from the INFUSE-AMI Trial).. 118. 2016
Comparison of Recent Trends in Patients With and Without Major Depression and Acute ST-Elevation Myocardial Infarction.. 118. 2016
Effects of Liver Transplantation on Lipids and Cardiovascular Disease in Children With Homozygous Familial Hypercholesterolemia.. 118. 2016
Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).. 118. 2016
Gender Differences in In-Hospital Outcomes After Coronary Artery Bypass Grafting.. 118. 2016
Community Screening for Nonischemic Cardiomyopathy in Asymptomatic Subjects ≥65 Years With Stage B Heart Failure.. 117. 2016
Frailty Status and Outcomes After Transcatheter Aortic Valve Implantation.. 117. 2016
Comparison of Trends in Incidence, Revascularization, and In-Hospital Mortality in ST-Elevation Myocardial Infarction in Patients With Versus Without Severe Mental Illness.. 117. 2016
Effect of Previous Failure on Subsequent Procedural Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention (from a Contemporary Multicenter Registry).. 117. 2016
Inhospital and Post-discharge Changes in Renal Function After Transcatheter Aortic Valve Replacement.. 117. 2015
Use of Coronary Computed Tomographic Angiography Findings to Modify Statin and Aspirin Prescription in Patients With Acute Chest Pain.. 117. 2015
Comparative Assessment of Mitral Regurgitation Severity by Transthoracic Echocardiography and Cardiac Magnetic Resonance Using an Integrative and Quantitative Approach.. 117. 2015
Should Antihypertensive Treatment Recommendations Differ in Patients With and Without Coronary Heart Disease? (from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial [ALLHAT]).. 117. 2015
Association Between Transcatheter Aortic Valve Implantation Volume and Outcomes in the United States.. 116. 2015
Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).. 116. 2015
Usefulness of the Left Anterior Descending Coronary Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).. 116. 2015
Clinical Features and outcomes in adults with cardiogenic shock supported by extracorporeal membrane oxygenation.. 116. 2015
Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents.. 116. 2015
Prevalence and Implications of Subclinical Coronary Artery Disease in Patients With Atrial Fibrillation.. 116. 2015
Usefulness of the Left Anterior Descending Artery Wrapping Around the Left Ventricular Apex to Predict Adverse Clinical Outcomes in Patients With Anterior Wall ST-Segment Elevation Myocardial Infarction (an INFUSE-AMI Substudy).. 115. 2015
Costs and in-hospital outcomes of transcatheter aortic valve implantation versus surgical aortic valve replacement in commercial cases using a propensity score matched model.. 115. 2015
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial).. 115. 2015
Effect of dietary sodium and potassium intake on left ventricular diastolic function and mass in adults≤40 years (from the Strong Heart Study).. 115. 2015
Outcomes of patients implanted with a left ventricular assist device at nontransplant mechanical circulatory support centers.. 115. 2015
Additive prognostic value of coronary artery calcium score over coronary computed tomographic angiography stenosis assessment in symptomatic patients without known coronary artery disease.. 115. 2015
Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).. 115. 2014
Impact of thrombus burden on outcomes after standard versus mesh-covered stents in acute myocardial infarction (from the MGuard for acute ST elevation reperfusion trial).. 115. 2014
Efficacy of an Embolic Protection Stent as a Function of Delay to Reperfusion in ST-Segment Elevation Myocardial Infarction (from the MASTER Trial).. 114. 2014
Impact of incidental amyloidosis on the prognosis of patients with hypertrophic cardiomyopathy undergoing septal myectomy for left ventricular outflow tract obstruction.. 114. 2014
Usefulness of arrhythmias as predictors of death and resource utilization in children with myocarditis.. 114. 2014
Rate of percutaneous coronary intervention for the management of acute coronary syndromes and stable coronary artery disease in the United States (2007 to 2011).. 114. 2014
Effect of peripheral vascular disease on mortality in cardiac transplant recipients (from the United Network of Organ Sharing Database).. 114. 2014
Impact of pre-procedural cardiopulmonary instability in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).. 114. 2014
Reference values for echocardiographic assessment of the diameter of the aortic root and ascending aorta spanning all age categories.. 114. 2014
Ability of low antihypertensive medication adherence to predict statin discontinuation and low statin adherence in patients initiating treatment after a coronary event.. 114. 2014
John Hunter: early association of Type A behavior with cardiac mortality.. 114. 2014
Usefulness of the electrocardiogram in predicting cardiovascular mortality in asymptomatic adults with aortic stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).. 114. 2014
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study).. 114. 2014
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial).. 114. 2014
Effect of myocardial perfusion pattern on frequency and severity of mitral regurgitation in patients with known or suspected coronary artery disease.. 114. 2014
Lung function and heart disease in American Indian adults with high frequency of metabolic abnormalities (from the Strong Heart Study).. 114. 2014
Body mass index and acute and long-term outcomes after acute myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).. 114. 2014
Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study).. 113. 2014
Impact of multiple complex plaques on short- and long-term clinical outcomes in patients presenting with ST-segment elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Trial).. 113. 2014
Outcomes in patients with ST-segment elevation acute myocardial infarction treated with clopidogrel versus prasugrel (from the INFUSE-AMI trial).. 113. 2014
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial).. 113. 2014
Comparison of outcomes in patients with ST-segment elevation myocardial infarction discharged on versus not on statin therapy (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trial).. 113. 2014
Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus.. 113. 2014
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial).. 113. 2013
Relation between coronary calcium and major bleeding after percutaneous coronary intervention in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy and Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction Trials).. 113. 2013
Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).. 113. 2013
Evaluation of lipids, drug concentration, and safety parameters following cessation of treatment with the cholesteryl ester transfer protein inhibitor anacetrapib in patients with or at high risk for coronary heart disease.. 113. 2013
Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).. 113. 2013
Influence of age-related versus non-age-related renal dysfunction on survival in patients with left ventricular dysfunction.. 113. 2013
Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations.. 113. 2013
Relations of plasma total and high-molecular-weight adiponectin to new-onset heart failure in adults ≥65 years of age (from the Cardiovascular Health study).. 113. 2013
Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).. 113. 2013
Prognostic utility of the SYNTAX score in patients with single versus multivessel disease undergoing percutaneous coronary intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).. 113. 2013
Outcomes of adolescents and adults undergoing primary Fontan procedure.. 112. 2013
Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).. 112. 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial).. 112. 2013
Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).. 112. 2013
Relation of preoperative serum albumin levels to survival in patients undergoing left ventricular assist device implantation.. 112. 2013
Usefulness of Q-wave area for threshold-based stratification of global left ventricular myocardial infarct size.. 112. 2013
Objective simulator-based evaluation of carotid artery stenting proficiency (from Assessment of Operator Performance by the Carotid Stenting Simulator Study [ASSESS]).. 112. 2013
Safety and efficacy of adjuvant glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention performed from the radial approach for acute ST segment elevation myocardial infarction.. 111. 2013
Distribution, determinants, and normal reference values of thoracic and abdominal aortic diameters by computed tomography (from the Framingham Heart Study).. 111. 2013
Frequency, mechanisms, and implications of late peri-stent contrast staining: analysis (from the HORIZONS-AMI Trial).. 111. 2013
Usefulness of preoperative exercise tolerance to predict late survival and symptom persistence after surgery for chronic nonischemic mitral regurgitation.. 111. 2013
Comparison of outcomes of patients with ST-segment elevation myocardial infarction with versus without previous coronary artery bypass grafting (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).. 111. 2013
Specialized delivery room planning for fetuses with critical congenital heart disease.. 111. 2013
Usefulness of the addition of beta-2-microglobulin, cystatin C and C-reactive protein to an established risk factors model to improve mortality risk prediction in patients undergoing coronary angiography.. 111. 2013
Transcatheter recanalization of totally occluded proximal pulmonary arteries and major systemic veins in patients with congenital heart disease.. 111. 2012
Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.. 110. 2012
Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis.. 110. 2012
Normal limits in relation to age, body size and gender of two-dimensional echocardiographic aortic root dimensions in persons ≥15 years of age.. 110. 2012
Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).. 110. 2012
Distribution of 10-year and lifetime predicted risk for cardiovascular disease prior to surgery in the longitudinal assessment of bariatric surgery-2 study.. 110. 2012
Cardiac transplantation in patients with hypertrophic cardiomyopathy.. 110. 2012
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry).. 110. 2012
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease.. 110. 2012
Long-term (5- to 20-year) outcomes after transcatheter or surgical treatment of hemodynamically significant isolated secundum atrial septal defect.. 109. 2012
Relation of mitral valve prolapse to basal left ventricular hypertrophy as determined by cardiac magnetic resonance imaging.. 109. 2012
Long-term outcomes with use of intravascular ultrasound for the treatment of coronary bifurcation lesions.. 109. 2012
Diabetes mellitus, myocardial reperfusion, and outcome in patients with acute ST-elevation myocardial infarction treated with primary angioplasty (from HORIZONS AMI).. 109. 2012
Comparison of the Diamond-Forrester method and Duke Clinical Score to predict obstructive coronary artery disease by computed tomographic angiography.. 109. 2012
Relation of the utility of exercise testing for risk assessment in pediatric patients with ventricular preexcitation to pathway location.. 109. 2012
Effect of changing heart rate during treatment of hypertension on incidence of heart failure.. 109. 2011
Analysis of circumferential and longitudinal left ventricular systolic function in patients with non-ischemic chronic heart failure and preserved ejection fraction (from the CARRY-IN-HFpEF study).. 109. 2011
Usefulness of two-dimensional echocardiographic parameters of the left side of the heart to predict right ventricular failure after left ventricular assist device implantation.. 109. 2011
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy).. 108. 2011
Predictors and implications of coronary infarct artery patency at initial angiography in patients with acute myocardial infarction (from the CADILLAC and HORIZONS-AMI Trials).. 108. 2011
Incidence, epidemiology, and prognosis of residual pulmonary hypertension after mitral valve repair for degenerative mitral regurgitation.. 107. 2011
Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention.. 107. 2011
Comparison of estimated glomerular filtration rates and albuminuria in predicting risk of coronary heart disease in a population with high prevalence of diabetes mellitus and renal disease.. 107. 2011
Usefulness of comprehensive cardiothoracic computed tomography in the evaluation of acute undifferentiated chest discomfort in the emergency department (CAPTURE).. 107. 2011
Intermediate to long-term outcome following congenital coronary artery fistulae closure with focus on thrombus formation.. 107. 2011
Usefulness of soluble concentrations of interleukin family member ST2 as predictor of mortality in patients with acutely decompensated heart failure relative to left ventricular ejection fraction.. 107. 2011
Comparison of adverse cardiovascular events and bleeding complications of loading dose of clopidogrel 300 mg versus 600 mg in stable patients undergoing elective percutaneous intervention (from the CADICE study).. 107. 2011
Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting.. 106. 2010
Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE Study).. 106. 2010
Effect of a standardized radiation dose reduction protocol on diagnostic accuracy of coronary computed tomographic angiography.. 106. 2010
Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.. 106. 2010
Usefulness of precordial T-wave inversion to distinguish arrhythmogenic right ventricular cardiomyopathy from idiopathic ventricular tachycardia arising from the right ventricular outflow tract.. 105. 2010
Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.. 105. 2010
Uncovering the septal Q wave and other electrocardiographic changes in pediatric patients with pre-excitation before and after ablation.. 105. 2010
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).. 105. 2010
Efficacy of high-dose clopidogrel treatment (600 mg) less than two hours before percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes.. 105. 2009
Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.. 104. 2009
Comparison of men and women with acute coronary syndrome in six Middle Eastern countries.. 104. 2009
Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during antihypertensive treatment (from the LIFE echo-substudy).. 104. 2009
Relation among lipoprotein subfractions and carotid atherosclerosis in Alaskan Eskimos (from the GOCADAN Study).. 104. 2009
Frequencies and types of arrhythmias in patients with systemic light-chain amyloidosis with cardiac involvement undergoing stem cell transplantation on telemetry monitoring.. 104. 2009
Impact of coronary computed tomographic angiography findings on the medical treatment and control of coronary artery disease and its risk factors.. 104. 2009
Comparison of cardiac computed tomographic angiography to transesophageal echocardiography for evaluation of patients with native valvular heart disease.. 104. 2009
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY).. 104. 2009
Usefulness of age and gender in the early triage of patients with acute chest pain having cardiac computed tomographic angiography.. 104. 2009
Effects of increasing high-density lipoprotein cholesterol and decreasing low-density lipoprotein cholesterol on the incidence of first acute coronary events (from the Air Force/Texas Coronary Atherosclerosis Prevention Study).. 104. 2009
Prognostic value of multiple biomarkers in American Indians free of clinically overt cardiovascular disease (from the Strong Heart Study).. 104. 2009
Value of orthopnea, paroxysmal nocturnal dyspnea, and medications in prospective population studies of incident heart failure.. 104. 2009
Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).. 104. 2009
Safety of cardiac catheterization in patients with end-stage liver disease awaiting liver transplantation.. 103. 2009
Presence and extent of coronary artery disease by cardiac computed tomography and risk for acute coronary syndrome in cocaine users among patients with chest pain.. 103. 2008
Differentiating ST elevation myocardial infarction and nonischemic causes of ST elevation by analyzing the presenting electrocardiogram.. 103. 2008
Relation of plaque characteristics defined by coronary computed tomographic angiography to ST-segment depression and impaired functional capacity during exercise treadmill testing in patients suspected of having coronary heart disease.. 103. 2008
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial).. 102. 2008
Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress.. 102. 2008
Long-term safety and efficacy of low-density lipoprotein apheresis in childhood for homozygous familial hypercholesterolemia.. 102. 2008
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction.. 102. 2008
Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.. 102. 2008
Influence of left atrial and ventricular volumes on the relation between mitral valve annulus and coronary sinus.. 102. 2008
Impact of perioperative myocardial infarction on angiographic and clinical outcomes following coronary artery bypass grafting (from PRoject of Ex-vivo Vein graft ENgineering via Transfection [PREVENT] IV).. 102. 2008
Effectiveness of anemia and chronic kidney disease as predictors for presence and severity of coronary artery disease in patients undergoing stress myocardial perfusion study.. 102. 2008
Causes of recurrent focal neurologic events after transcatheter closure of patent foramen ovale with the CardioSEAL septal occluder.. 101. 2008
Relation of albuminuria to left ventricular mass (from the HyperGEN Study).. 101. 2008
Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004).. 101. 2007
Frequency of aberrant subclavian artery, arch laterality, and associated intracardiac anomalies detected by echocardiography.. 101. 2007
Comparison of percutaneous versus surgical revascularization of severe unprotected left main coronary stenosis in matched patients.. 101. 2007
Prevalence of an increased ascending thoracic aorta diameter diagnosed by two-dimensional echocardiography versus 64-multislice cardiac computed tomography.. 101. 2007
Survey of current practices of the specialty of physicians interpreting cardiac and noncardiac findings of coronary computed tomographic angiography.. 100. 2007
Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein.. 100. 2007
Prevalence of an increased ascending and descending thoracic aorta diameter diagnosed by multislice cardiac computed tomography in men versus women and in persons aged 23 to 50 years, 51 to 65 years, 66 to 80 years, and 81 to 88 years.. 100. 2007
Clinical and angiographic correlates of short- and long-term mortality in patients undergoing coronary artery bypass grafting.. 100. 2007
Comparison of age, body mass index, and frequency of systemic hypertension and diabetes mellitus in patients having coronary angioplasty in 1996 versus in 2006.. 100. 2007
Prognostic value of exercise tolerance testing in asymptomatic chronic nonischemic mitral regurgitation.. 100. 2007
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).. 100. 2007
Usefulness of magnetic resonance angiography in the evaluation of complex congenital heart disease in newborns and infants.. 100. 2007
Usefulness of quantitative assessment of electrocardiographic ST depression for predicting new-onset heart failure in American Indians (from the Strong Heart Study).. 100. 2007
Frequency of development of aortic cuspal prolapse and aortic regurgitation in patients with subaortic ventricular septal defect diagnosed at <1 year of age.. 99. 2007
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.. 99. 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.. 99. 2007
In vitro validation of real-time three-dimensional color Doppler echocardiography for direct measurement of proximal isovelocity surface area in mitral regurgitation.. 99. 2007
Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).. 99. 2007
Relation between mitral annular calcium and complex aortic atheroma in patients with cerebral ischemia referred for transesophageal echocardiography.. 99. 2007
Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism.. 99. 2007
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).. 99. 2007
Usefulness of multidetector spiral computed tomography according to age and gender for diagnosis of acute pulmonary embolism.. 99. 2007
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.. 99. 2007
Prevalence and clinical implications of improper filter settings in routine electrocardiography.. 99. 2007
Outcomes following immediate (ad hoc) versus staged percutaneous coronary interventions (report from the 2000 to 2001 New York State Angioplasty Registry).. 99. 2006
Effect of ranitidine on the antiplatelet effects of aspirin in healthy human subjects.. 99. 2006
Comparison of the efficacy of direct coronary stenting with sirolimus-eluting stents versus stenting with predilation by intravascular ultrasound imaging (from the DIRECT trial).. 98. 2006
Effect of clopidogrel plus aspirin on ST segments in patients with ST-elevation acute myocardial infarction.. 98. 2006
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry).. 98. 2006
A phase 1-2 dose-escalating study evaluating the safety and tolerability of istaroxime and specific effects on electrocardiographic and hemodynamic parameters in patients with chronic heart failure with reduced systolic function.. 99. 2006
Temporal trends in the use of early cardiac catheterization in patients with non-ST-segment elevation acute coronary syndromes (results from CRUSADE).. 98. 2006
Use of platelet glycoprotein IIb/IIIa inhibitors in saphenous vein graft percutaneous coronary intervention and clinical outcomes.. 98. 2006
Gender differences in left ventricular systolic function in American Indians (from the Strong Heart Study).. 98. 2006
Evaluation of global and regional right ventricular systolic function in patients with pulmonary hypertension using a novel speckle tracking method.. 98. 2006
Relation of C-reactive protein level and long-term risk of death or myocardial infarction following percutaneous coronary intervention with a sirolimus-eluting stent.. 98. 2006
Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes.. 98. 2006
Comparison of bare metal stents versus drug-eluting stents on clinical decision making in patients with previous percutaneous coronary intervention admitted for suspected acute coronary syndrome.. 98. 2006
Comparison of results of percutaneous coronary intervention for non-ST-elevation acute myocardial infarction or unstable angina pectoris in men versus women.. 98. 2006
Relation of QT interval measurements to evolving automated algorithms from different manufacturers of electrocardiographs.. 98. 2006
Gender differences of revascularization in patients with acute myocardial infarction.. 97. 2006
Dynamic expression of the membrane attack complex (MAC) of the complement system in failing human myocardium.. 97. 2006
Modifications of coronary risk factors.. 97. 2006
Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy).. 97. 2006
The fate of patients with clinical recurrence after sirolimus-eluting stent implantation (a two-year follow-up analysis from the SIRIUS trial).. 97. 2006
Racial differences in the association of coronary calcified plaque with left ventricular hypertrophy: the National Heart, Lung, and Blood Institute Family Heart Study and Hypertension Genetic Epidemiology Network.. 97. 2006
Yield of transesophageal echocardiography for nonbacterial thrombotic endocarditis and other cardiac sources of embolism in cancer patients with cerebral ischemia.. 97. 2006
Comparative cost-effectiveness of B-type natriuretic peptide and echocardiography for predicting outcome in patients with congestive heart failure.. 97. 2006
Usefulness of isovolumic and systolic ejection signals by tissue Doppler for the assessment of left ventricular systolic function in ischemic or idiopathic dilated cardiomyopathy.. 97. 2006
Blood pressure stress reactivity and left ventricular mass in a random community sample of African-American and caucasian men and women.. 97. 2006
Angiographic pattern of restenosis following implantation of overlapping sirolimus-eluting (Cypher) stents.. 97. 2006
Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III guidelines.. 96. 2005
Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies.. 96. 2005
Prognostic impact of systolic hypertension on asymptomatic patients with chronic severe aortic regurgitation and initially normal left ventricular performance at rest.. 96. 2005
Anatomic distribution of myocardial ischemia as a determinant of exercise-induced ST-segment depression.. 96. 2005
Frequency, predictors, and outcomes of drug-eluting stent utilization in patients with high-risk non-ST-segment elevation acute coronary syndromes.. 96. 2005
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.. 96. 2005
Neurological complications following percutaneous coronary interventions (a report from the 2000-2001 New York State Angioplasty Registry).. 96. 2005
Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery.. 96. 2005
Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.. 96. 2005
Left ventricular ejection fraction and prevalence of new left ventricular wall motion abnormality at long-term follow-up in patients with automatic implantable cardioverter-defibrillators treated with dual-chamber rate-responsive pacing at a rate of 70/minute versus backup ventricular pacing at a rate of 40/minute.. 96. 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.. 95. 2005
Effectiveness of automated external defibrillators in high schools in greater Boston.. 95. 2005
Influence of stent length to lesion length ratio on angiographic and clinical outcomes after implantation of bare metal and drug-eluting stents (the TAXUS-IV Study).. 95. 2005
Relation of myocardial perfusion to mortality after primary percutaneous coronary intervention.. 95. 2005
Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).. 95. 2005
Depressive symptoms are independently predictive of carotid atherosclerosis.. 95. 2005
Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction.. 95. 2005
Statin use and risks of death or fatal rejection in the Heart Transplant Lipid Registry.. 95. 2005
Usefulness of prolonged QRS duration to identify high-risk ischemic cardiomyopathy patients with syncope and inducible ventricular tachycardia.. 95. 2005
Incremental prognostic power of single-photon emission computed tomographic myocardial perfusion imaging in patients with known or suspected coronary artery disease.. 95. 2005
Left ventricular structure and function in sedentary and physically active subjects with left ventricular hypertrophy (the LIFE Study).. 95. 2005
New predictors of outcome in idiopathic pulmonary arterial hypertension.. 95. 2005
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).. 95. 2005
Revascularization among patients with acute myocardial infarction complicated by cardiogenic shock and impact of American College of Cardiology/American Heart Association guidelines.. 94. 2004
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).. 94. 2004
Relation of clinical success in coronary brachytherapy to dose.. 94. 2004
Relation of an elevated white blood cell count after percutaneous coronary intervention to long-term mortality.. 94. 2004
Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions.. 94. 2004
Prevalence of hypertrophic cardiomyopathy in a population-based sample of American Indians aged 51 to 77 years (the Strong Heart Study).. 93. 2004
Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion.. 93. 2004
Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).. 93. 2004
Comparative accuracy of B-type natriuretic peptide and tissue Doppler echocardiography in the diagnosis of congestive heart failure.. 93. 2004
Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial).. 93. 2004
Validation of viability assessment by electromechanical mapping by three-dimensional reconstruction with dobutamine stress echocardiography in patients with coronary artery disease.. 93. 2004
Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.. 93. 2004
Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (results of the LOWTEMP pilot study).. 93. 2004
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).. 93. 2004
Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the Strong Heart Study).. 93. 2004
Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA.. 92. 2003
Intracardiac echocardiography during transcatheter interventions for congenital heart disease.. 92. 2003
Revisiting optimal anticoagulation with unfractionated heparin during coronary stent implantation.. 92. 2003
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).. 92. 2003
Effect of age and gender on heart rate recovery after submaximal exercise during cardiac rehabilitation in patients with angina pectoris, recent acute myocardial infarction, or coronary bypass surgery.. 92. 2003
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).. 92. 2003
Effect of revascularization on mortality associated with an elevated white blood cell count in acute coronary syndromes.. 92. 2003
Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study).. 91. 2003
Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow propagation velocity.. 91. 2003
Safe and efficacious use of bivalirudin for percutaneous coronary intervention with adjunctive platelet glycoprotein IIb/IIIa receptor inhibition.. 91. 2003
Effect of uncoated stenting versus balloon angioplasty alone of long coronary (>20 mm) versus shorter narrowings on one-year event-free survival.. 91. 2003
Muscle sympathetic nerve traffic during spontaneous- versus adenosine-mediated termination of idiopathic right ventricular outflow tract tachycardia.. 91. 2003
Heart rate recovery response to symptom-limited treadmill exercise after cardiac rehabilitation in patients with coronary artery disease with and without recent events.. 90. 2002
Relation of tissue Doppler-derived myocardial velocities to serum levels and myocardial gene expression of tumor necrosis factor-alpha and inducible nitric oxide synthase in patients with ischemic cardiomyopathy having coronary artery bypass grafting.. 90. 2002
Efficacy and safety of multivessel percutaneous revascularization and tirofiban therapy in patients with acute coronary syndromes.. 90. 2002
Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication.. 90. 2002
Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency.. 89. 2002
Gender difference in diastolic function in hypertension (the HyperGEN study).. 89. 2002
Significance of sustained monomorphic ventricular tachycardia induced with short coupling intervals in patients with ischemic cardiomyopathy.. 89. 2002
Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit.. 89. 2002
Peak early diastolic velocity rather than pressure half-time is the best index of mechanical prosthetic mitral valve function.. 89. 2002
Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study).. 89. 2002
Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention.. 89. 2002
Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).. 89. 2002
Effect of local delivery of L-arginine on in-stent restenosis in humans.. 89. 2002
Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia.. 89. 2002
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).. 89. 2002
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).. 88. 2001
Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus.. 88. 2001
Relation of various degrees of body mass index in patients with systemic hypertension to left ventricular mass, cardiac output, and peripheral resistance (The Hypertension Genetic Epidemiology Network Study).. 88. 2001
Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study).. 88. 2001
Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients.. 88. 2001
Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction.. 88. 2001
Separate and joint effects of systemic hypertension and diabetes mellitus on left ventricular structure and function in American Indians (the Strong Heart Study).. 87. 2001
Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TEXCAPS): additional perspectives on tolerability of long-term treatment with lovastatin.. 87. 2001
Frequency of subacute resumption of isthmus conduction after ablation of atrial flutter.. 87. 2001
Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study).. 87. 2001
The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry.. 87. 2001
Prevalence and relation to risk factors of carotid atherosclerosis and left ventricular hypertrophy in systemic lupus erythematosus and antiphospholipid antibody syndrome.. 87. 2001
Inappropriate left ventricular mass in normotensive and hypertensive patients.. 87. 2001
Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study).. 87. 2001
QT dispersion, T-wave projection, and heterogeneity of repolarization in patients with coronary artery disease.. 87. 2001
Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.. 87. 2001
Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension.. 87. 2001
Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group.. 86. 2000
Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study.. 86. 2000
Continuous intravenous diltiazem infusion for short-term ventricular rate control in children.. 86. 2000
Pulsed Doppler echocardiographic assessment of the fetal PR interval.. 86. 2000
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension.. 85. 2000
The benefit of abciximab in percutaneous coronary revascularization is not device-specific.. 85. 2000
A comparison of ionic versus nonionic contrast medium during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction (GUSTO IIb). Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes.. 85. 2000
Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.. 85. 2000
Vasopressin in the treatment of milrinone-induced hypotension in severe heart failure.. 85. 2000
Severe mitral regurgitation due to mitral valve prolapse: risk factors for development, progression, and need for mitral valve surgery.. 85. 2000
Estimation of mean right atrial pressure using tissue Doppler imaging.. 84. 1999
Chest pain--a strong predictor of adverse cardiac events following precutaneous intervention (from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting Trial [EPISENT])].. 84. 1999
Hemodynamic and functional consequences of radial artery removal for coronary artery bypass grafting.. 84. 1999
Factors leading to progression of valvular aortic stenosis.. 84. 1999
Effectiveness of early coronary angioplasty and abciximab for failed thrombolysis (reteplase or alteplase) during acute myocardial infarction (results from the GUSTO-III trial). Global Use of Strategies To Open occluded coronary arteries.. 84. 1999
Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty. RAPPORT investigators. ReoPro And Primary PTCA Organization and Randomized Trial.. 84. 1999
Effectiveness of aspirin and clopidogrel combination therapy in coronary stenting.. 84. 1999
Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin.. 84. 1999
Relations of diastolic left ventricular filling to systolic chamber and myocardial contractility in hypertensive patients with left ventricular hypertrophy (The PRESERVE Study).. 84. 1999
Intracardiac Doppler hemodynamics and flow: new vector, phased-array ultrasound-tipped catheter.. 83. 1999
Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome.. 83. 1999
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension.. 83. 1999
Correlation of serum lipoprotein(a) with the angiographic and clinical presentation of coronary artery disease.. 83. 1999
Usefulness of transthoracic echocardiography in detecting significant prosthetic mitral valve regurgitation.. 83. 1999
Comparison of left ventricular function during interval versus steady-state exercise training in patients with chronic congestive heart failure.. 82. 1998
Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension.. 82. 1998
The Lipoprotein and Coronary Atherosclerosis Study (LCAS) in context: assessing the benefits of lipid-lowering therapy. Introduction.. 82. 1998
A family study of anterior mitral leaflet thickness and mitral valve prolapse.. 82. 1998
Estimation of left and right ventricular filling pressures after heart transplantation by tissue Doppler imaging.. 82. 1998
Platelet glycoprotein IIb/IIIa receptor blockade with abciximab reduces ischemic complications in patients undergoing directional coronary atherectomy. EPILOG Investigators. Evaluation of PTCA to Improve Long-term Outcome by c7E3 GP IIb/IIIa Receptor Blockade.. 82. 1998
Quantitative angiography of coronary artery dimensions 24 hours after rotational atherectomy.. 81. 1998
Diagnostic accuracy of stress thallium-201 tomography in patients with left ventricular hypertrophy.. 81. 1998
Design of a randomized, placebo-controlled multicenter trial on the long-term effects of intermittent transdermal nitroglycerin on left ventricular remodeling after acute myocardial infarction. Transdermal Nitroglycerin Investigators Group.. 81. 1998
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group.. 81. 1998
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.. 81. 1998
Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study). 80. 1997
Palliative coronary artery surgery in patients with severe noncardiac diseases.. 80. 1997
Application of the continuity equation and valve resistance to the evaluation of St. Jude Medical prosthetic aortic valve dysfunction.. 80. 1997
Design & rationale of the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).. 80. 1997
Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]).. 80. 1997
Late myocardial ischemic events after saphenous vein graft intervention--importance of initially "nonsignificant" vein graft lesions.. 79. 1997
Relation of ultra-low frequency heart rate variability to the clinical course of chronic aortic regurgitation.. 79. 1997
Usefulness of subnormal midwall fractional shortening in predicting left ventricular exercise dysfunction in asymptomatic patients with systemic hypertension.. 79. 1997
Comparison of ambulatory blood pressure and amounts of left ventricular hypertrophy in men versus women with similar levels of hypertensive clinic blood pressures.. 79. 1997
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).. 79. 1997
Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB).. 79. 1997
Comparison of patients with either < 70% diameter narrowing or > or = 70% narrowing of the right coronary artery when performing rotational atherectomy on > or = 1 narrowing in the left coronary arteries.. 79. 1997
Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.. 79. 1997
Comparison of stenting and balloon angioplasty for narrowings in aortocoronary saphenous vein conduits in place for more than five years.. 79. 1997
Major electrocardiographic abnormalities among American Indians aged 45 to 74 years (the Strong Heart Study).. 78. 1996
Thrombolytic therapy for patients with prior percutaneous transluminal coronary angioplasty and subsequent acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.. 78. 1996
Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella.. 78. 1996
A comparison of debulking versus dilatation of bifurcation coronary arterial narrowings (from the CAVEAT I Trial). Coronary Angioplasty Versus Excisional Atherectomy Trial-I.. 78. 1996
Rhythm annotation and interobserver reproducibility of measures of heart rate variability.. 78. 1996
Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography.. 78. 1996
The Sir James Mackenzie Cardiological Society and the American College of Cardiology.. 78. 1996
Clinical and angiographic significance of a normal thallium-201 tomographic study in patients with a strongly positive exercise electrocardiogram.. 78. 1996
Assessment of left ventricular function by meridional and circumferential end-systolic stress/minor-axis shortening relations in dilated cardiomyopathy.. 78. 1996
Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial).. 78. 1996
Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension.. 77. 1996
Relation of patient characteristics to cardiac ischemia during daily life activity (an Asymptomatic Cardiac Ischemia Pilot Data Bank Study).. 77. 1996
Angiographic correlates of cardiac death and myocardial infarction complicating major nonthoracic vascular surgery.. 77. 1996
Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry.. 77. 1996
Relation of ventricular size and function to heart failure status and ventricular dysrhythmia in patients with severe left ventricular dysfunction.. 77. 1996
Left ventricular filling pattern in uncomplicated obesity.. 77. 1996
Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis in Myocardial Ischemia III Registry).. 77. 1996
Chronotropic response to exercise predicts angiographic severity in patients with suspected or stable coronary artery disease.. 76. 1995
Immediate and reversible platelet inhibition after intravenous administration of a peptide glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention.. 76. 1995
Association of increased left ventricular mass in the absence of electrocardiographic left ventricular hypertrophy with ST depression during exercise.. 76. 1995
Impact of echocardiographic left ventricular mass on mechanistic implications of exercise testing parameters.. 76. 1995
Improvement in noninvasive electrophysiologic findings in children after transcatheter atrial septal defect closure.. 76. 1995
Doppler echocardiographic assessment with the continuity equation of St. Jude Medical mechanical prostheses in the mitral valve position.. 76. 1995
Exercise thallium-201 single photon emission computed tomography for evaluation of coronary artery bypass graft patency.. 76. 1995
Feasibility and accuracy of Doppler echocardiographic estimation of pulmonary artery occlusive pressure in the intensive care unit.. 75. 1995
"Dr. Anonymous" unmasked: resolution of an eighteenth century mystery in the history of coronary artery disease.. 75. 1995
High reproducibility of myocardial perfusion defects in patients undergoing serial exercise thallium-201 tomography.. 75. 1995
Natural history of mitral valve prolapse.. 75. 1995
Intravascular ultrasound assessment of biliary stent implantation in saphenous vein grafts.. 75. 1995
Isovolumic relaxation flow detected by Doppler echocardiography in patients undergoing right ventricular pacing.. 75. 1995
Failure to decrease parasympathetic tone during upright tilt predicts a positive tilt-table test.. 75. 1995
Transient loss of complete bundle branch block patterns during exercise.. 75. 1995
Coronary stenting with angioscopic guidance.. 75. 1995
Serial intravascular ultrasound studies fail to show evidence of chronic Palmaz-Schatz stent recoil.. 75. 1995
Life expectancy in the Marfan syndrome.. 75. 1995
Coronary stenting for treatment of ostial stenoses of native coronary arteries or aortocoronary saphenous venous grafts.. 75. 1995
Indications for low-density lipoprotein apheresis.. 74. 1994
Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur.. 74. 1994
Reproducibility of power spectral measures of heart rate variability obtained from short-term sampling periods.. 74. 1994
Variability of the ventricular response in atrial fibrillation and prognosis in chronic nonischemic mitral regurgitation.. 74. 1994
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects.. 74. 1994
Exploring the minimal dose of amiodarone with antiarrhythmic and hemodynamic activity.. 74. 1994
Permanent pacing following repeat cardiac valve surgery.. 74. 1994
Natural history of the asymptomatic/minimally symptomatic patient with severe mitral regurgitation secondary to mitral valve prolapse and normal right and left ventricular performance.. 74. 1994
Body fat distribution and whole blood viscosity in a sample of Italian men and women.. 74. 1994
Clinical impact of transesophageal echocardiography in the diagnosis and management of infective endocarditis.. 73. 1994
In vivo mitral valve morphology and motion in mitral valve prolapse.. 73. 1994
Baseline characteristics of subjects in the Lipoprotein and Coronary Atherosclerosis Study (LCAS) with fluvastatin.. 73. 1994
Discontinuation of chronic diuretic therapy in stable congestive heart failure secondary to coronary artery disease or to idiopathic dilated cardiomyopathy.. 73. 1994
Dissection of the ascending aorta associated with coronary angiography.. 73. 1994
Incidence and prediction of induced ventricular tachyarrhythmias in idiopathic dilated cardiomyopathy.. 73. 1994
Limitations of adenosine in assessing the efficacy of radiofrequency catheter ablation of accessory pathways.. 73. 1994
Clinical and health care cost consequences of infective endocarditis in mitral valve prolapse.. 73. 1994
Safety of single-site adenosine thallium-201 scintigraphy.. 73. 1994
Comparative effects of atenolol versus celiprolol on serum lipids and blood pressure in hyperlipidemic and hypertensive subjects.. 72. 1993
Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibody. The TAMI Study Group.. 72. 1993
Therapeutic significance of exercise-induced ST-segment elevation in patients without previous myocardial infarction.. 72. 1993
Once-daily, extended-release gemfibrozil in patients with dyslipidemia. The Lopid SR Work Group I.. 71. 1993
Rapid redistribution of teboroxime.. 71. 1993
Comparison of sustained-release formulations of nicardipine and verapamil for mild to moderate systemic hypertension.. 70. 1992
Effects of morbid obesity and diabetes mellitus on risk of coronary artery bypass grafting.. 70. 1992
A symposium: triglycerides as a vascular risk factor: a global forum. Introduction.. 70. 1992
Effects on platelet aggregation and fibrinolytic activity during upright posture and exercise in healthy men.. 70. 1992
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group.. 70. 1992
Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events.. 70. 1992
Identifying coronary artery disease in women by heart rate adjustment of ST-segment depression and improved performance of linear regression over simple averaging method with comparison to standard criteria.. 69. 1992
Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/American Heart Association grading criteria.. 69. 1992
Gender differences in left ventricular anatomy, blood viscosity and volume regulatory hormones in normal adults.. 68. 1991
Incidence of QT interval prolongation during pentamidine therapy of Pneumocystis carinii pneumonia.. 68. 1991
Time-motion reconstruction of mitral leaflet motion from two-dimensional echocardiography in mitral valve prolapse.. 68. 1991
Myocardial perfusion scintigraphy during maximal coronary artery vasodilation with adenosine.. 67. 1991
A generalized description of Wenckebach behavior with analysis of determinants of ventricular cycle-length variation during ambulatory electrocardiography.. 67. 1991
Determination of severity of valvular aortic stenosis by Doppler echocardiography and relation of findings to clinical outcome and agreement with hemodynamic measurements determined at cardiac catheterization.. 67. 1991
An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction.. 67. 1991
Spontaneous myocardial ischemia and the signal-averaged electrocardiogram.. 67. 1991
Late results of the left subcostal approach for automatic implantable cardioverter defibrillator implantation.. 67. 1991
Risk of dysphagia after transesophageal echocardiography.. 67. 1991
Functional significance of myocardial perfusion defects induced by dipyridamole using thallium-201 single-photon emission computed tomography and two-dimensional echocardiography.. 66. 1990
Ventricular tachycardia and torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.. 66. 1990
Clinical relevance of exercise-induced ventricular arrhythmias in suspected coronary artery disease.. 66. 1990
Antiarrhythmic and hemodynamic evaluation of indecainide and procainamide in nonsustained ventricular tachycardia.. 66. 1990
Fractal clustering of ventricular ectopy in dilated cardiomyopathy.. 65. 1990
Preoperative left and right ventricular performance in combined aortic and mitral regurgitation and comparison with isolated aortic or mitral regurgitation.. 65. 1990
Relation of prognosis in sick sinus syndrome to age, conduction defects and modes of permanent cardiac pacing.. 65. 1990
Medical costs of coronary artery disease in the United States.. 65. 1990
Lack of correlation between transient myocardial ischemia and late potentials on the signal-averaged electrocardiogram.. 65. 1990
Blood cholesterol screening in several environments using a portable, dry-chemistry analyzer and fingerstick blood samples. Lipid Research Clinics Cholesterol Screening Study Group.. 65. 1990
Ability of left ventricular stress-shortening relations, end-systolic stress/volume ratio and indirect indexes to detect severe contractile failure in ischemic or idiopathic dilated cardiomyopathy.. 64. 1989
Computer-based implementation of the ST-segment/heart rate slope.. 64. 1989
Prevalence, time course and malignancy of ventricular arrhythmia during spontaneous ischemic ST-segment depression.. 64. 1989
Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.. 64. 1989
Noninvasive ambulatory blood pressure monitoring in patients with recently detected systemic hypertension.. 64. 1989
Two-dimensional echocardiographic aortic root dimensions in normal children and adults.. 64. 1989
Role of bandpass filters in optimizing the value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation.. 64. 1989
The R on T phenomenon during transient myocardial ischemia.. 63. 1989
Effect of intravenous magnesium sulfate on supraventricular tachycardia.. 63. 1989
Renovascular reconstruction: factors affecting long-term prognosis in 919 patients followed up to 31 years.. 63. 1989
Effects of intravenous metoprolol on global and regional left ventricular function after coronary arterial reperfusion in acute myocardial infarction.. 63. 1989
Acute myocardial infarction during Holter recording.. 63. 1989
Comparison of cardiovascular and skeletal features of primary mitral valve prolapse and Marfan syndrome.. 63. 1989
Early intravenous thrombolytic therapy for acute myocardial infarction in patients with prior coronary artery bypass grafts.. 63. 1989
Treatment of symptomatic peripheral atherosclerotic disease with a rotational atherectomy device.. 63. 1989
Lack of association between acute myocardial infarction and mitral valve prolapse.. 62. 1988
Heart rate adjustment of ST-segment depression for reduction of false positive electrocardiographic responses to exercise in asymptomatic men screened for coronary artery disease.. 62. 1988
Influence of left atrial systolic emptying on left ventricular early filling dynamics by Doppler in patients with sequential atrioventricular pacemakers.. 62. 1988
Simultaneous low level treadmill exercise and intravenous dipyridamole stress thallium imaging.. 62. 1988
Comparison of mitral valve dimensions and motion in mitral valve prolapse with severe mitral regurgitation to uncomplicated mitral valve prolapse and to mitral regurgitation without mitral valve prolapse.. 62. 1988
Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension.. 62. 1988
Value of the signal-averaged electrocardiogram as a predictor of the results of programmed stimulation in nonsustained ventricular tachycardia.. 61. 1988
Clinical features of mitral valve prolapse associated with low body weight.. 61. 1988
Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and location.. 61. 1988
Usefulness of adenosine for arrhythmias in infants and children.. 61. 1988
Hemodynamic hypertrophied left ventricular patterns in systemic hypertension.. 60. 1987
Effects of Ethmozine (moricizine HCl) on ventricular function using echocardiographic, hemodynamic and radionuclide assessments.. 60. 1987
Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions.. 60. 1987
Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography Committee for Physician Training in Echocardiography.. 60. 1987
Quantification of atrial contribution to left ventricular filling by pulsed Doppler echocardiography and the effect of age in normal and diseased hearts.. 59. 1987
Relation of Doppler-derived left ventricular filling parameters to age and radius/thickness ratio in normal and pathologic states.. 59. 1987
Cardiac structure and function in renovascular hypertension produced by unilateral and bilateral renal artery stenosis.. 58. 1986
Atrial pacing for conversion of atrial flutter.. 58. 1986
Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-I in women.. 58. 1986
Randomized double-blind trial of intravenous streptokinase for acute myocardial infarction.. 58. 1986
Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy.. 57. 1986
Frequency of angiographically significant coronary arterial narrowing in mitral stenosis.. 57. 1986
A multicenter, randomized, double-blind dose-response evaluation of step-2 guanfacine versus placebo in mild to moderate hypertension.. 57. 1986
Angina pectoris and coronary artery disease in isolated, severe aortic regurgitation.. 57. 1986
Detection of diastolic atrioventricular valvular regurgitation by pulsed Doppler echocardiography and its association with complete heart block.. 57. 1986
Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.. 57. 1986
De novo refractory ventricular tachyarrhythmias after coronary revascularization.. 57. 1986
Relation of hemoglobin A1 and blood glucose to cardiac function in diabetes mellitus.. 56. 1985
Correlation of the exercise ST/HR slope with anatomic and radionuclide cineangiographic findings in stable angina pectoris.. 56. 1985
Analysis of the spontaneous variability of ventricular arrhythmias: consecutive ambulatory electrocardiographic recordings of ventricular tachycardia.. 56. 1985
Complex arrhythmias in mitral regurgitation with and without mitral valve prolapse: contrast to arrhythmias in mitral valve prolapse without mitral regurgitation.. 55. 1985
Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.. 55. 1985
Relation of angina pectoris to coronary artery disease in aortic valve stenosis.. 55. 1985
Detection of platelet deposition at the site of peripheral balloon angioplasty using indium-111 platelet scintigraphy.. 55. 1985
Improved accuracy of the exercise electrocardiogram: identification of three-vessel coronary disease in stable angina pectoris by analysis of peak rate-related changes in ST segments.. 55. 1985
Arrhythmias in ischemic and nonischemic dilated cardiomyopathy: prediction of mortality by ambulatory electrocardiography.. 55. 1985
Some unanswered problems with probability analysis: possible impact on exercise thallium test use.. 55. 1985
Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.. 54. 1984
Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension.. 54. 1984
Radionuclide ventriculographic responses to graded supine and upright exercise: critical role of the Frank-Starling mechanism at submaximal exercise.. 53. 1984
Lack of association between dermal arches and mitral valve prolapse: relation to anxiety.. 53. 1984
High-density lipoproteins: biochemical and metabolic factors.. 52. 1983
Evaluation of metoprolol in suppressing complex ventricular arrhythmias.. 52. 1983
Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillation.. 51. 1983
Can noninvasive exercise test criteria identify patients with left main or 3-vessel coronary disease after a first myocardial infarction?. 51. 1983
Radionuclide ventriculographic study of adaptations to exercise in aortic regurgitation.. 51. 1983
Relation of hemodynamic load to left ventricular hypertrophy and performance in hypertension.. 51. 1983
The early pathophysiolic understanding of angina pectoris (Edward Jenner, Caleb Hillier Parry, Alan Burns).. 50. 1982
Transluminal laser catheter angioplasty.. 50. 1982
Can exercise electrocardiography and thallium-201 myocardial imaging exclude the diagnosis of coronary artery disease? Bayesian analysis of the clinical limits of exclusion and indications for coronary angiography.. 49. 1982
Importance of preoperative hypertrophy, wall stress and end-systolic dimension as echocardiographic predictors of normalization of left ventricular dilatation after valve replacement in chronic aortic insufficiency.. 49. 1982
Unstable angina pectoris: National Cooperative Study Group to Compare Medical and Surgical Therapy. IV. Results in patients with left descending coronary artery disease.. 48. 1981
Noninvasive detection of left ventricular dysfunction with a portable electrocardiographic gated scintillation probe device.. 47. 1981
Pulsed Doppler echocardiographic detection of right-sided valve regurgitation. Experimental results and clinical significance.. 47. 1981
Quantification of valve regurgitation by radionuclide angiography before and after valve replacement surgery.. 47. 1981
The frustrated benevolence of "Dr. Anonymous".. 47. 1981
Isolated stenosis of left anterior descending or right coronary artery: relation between site of stenosis and ventricular dysfunction and therapeutic implications.. 46. 1980
Diagnosis and quantification of aortic stenosis with pulsed Doppler echocardiography.. 45. 1980
Noninvasive quantification of left ventricular wall stress. Validation of method and application to assessment of chronic pressure overload.. 45. 1980
Unstable angina pectoris: national cooperative study group to compare surgical and medical therapy. III. Results in patients with S-T segment elevation during pain.. 45. 1980
John Hunter, angina pectoris and medical education.. 45. 1980
Improved survival beyond 5 years after coronary bypass surgery in patients with left main coronary artery disease.. 44. 1979
Poststress redistribution of thallium-201 in patients with coronary artery disease, with and without prior myocardial infarction.. 43. 1979
Spectrum of exercise thallium-201 myocardial perfusion imaging in patients with chest pain and normal coronary angiograms.. 43. 1979
Improved survival after 5 years in 1,144 patients after coronary bypass surgery.. 42. 1978
Unstable angina pectoris: National Cooperative Study Group to Compare Surgical and Medical Therapy.. 42. 1978
Aortocoronary bypass saphenous vein graft atherosclerosis. Anatomic study of 99 vein grafts from normal and hyperlipoproteinemic patients up to 75 months postoperatively.. 40. 1977
Results of coronary bypass more than 5 years after operation in 434 patients. Clinical, treadmill exercise and angiographic correlations.. 40. 1977
Vein graft patency and intimal proliferation after aortocoronary bypass: early and long-term angiopathologic correlations.. 38. 1976
Unstable angina pectoris: national cooperative study group to compare medical and surgical therapy. I. Report of protocol and patient population.. 37. 1976
Diastolic compliance of the left ventricle in man.. 36. 1975
Noninvasive assessment of clinical response to oral propranolol therapy.. 35. 1975
Prinzmetal's variant angina: hemodynamic and angiographic observations during pain.. 35. 1975
Electrocardiographic and serum enzyme changes of myocardial infarction after coronary artery bypass surgery.. 33. 1974
Pseudomonas endocarditis.. 32. 1973
Practical exercise test for physical fitness and cardiac performance.. 30. 1972
Isolated tricuspid valvular stenosis.. 26. 1970
Isolated tricuspid valvular stenosis.. 25. 1970
Multiple Arterial Grafting: A Critical Analysis.. 132. 2020
PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension.. 127. 2020
Reply to "ALLHAT Recommendations for Antihypertensive Therapy".. 120. 2016
Reply: To PMID 25784513.. 116. 2015
Reply to Madias et al. Is the different frequency of T-wave inversion in arrhythmogenic right ventricular cardiomyopathy and idiopathic ventricular tachycardia due to different frequency and duration of ventricular ectopy inducing a different degree of cardiac memory effect? Am J Cardiol 2010;106:1522.. 107. 2011
More studies are needed on gender-based outcomes in percutaneous coronary intervention with drug-eluting stents.. 100. 2007
Cost of lipid-lowering statin drugs.. 77. 1996
Survival in coronary artery disease compared with age- and sex-specific U.S. population.. 53. 1984
Myocardial metabolic alterations after contrast angiography.. 52. 1983
Anginal chest pain versus angina pectoris.. 43. 1979
Healthcare Expenditure Associated With Polypharmacy in Older Adults With Cardiovascular Diseases. 2022
Prescribing Trend of Inappropriate Medications in Outpatient Clinics for Older Adults With Heart Failure in the United States: NAMCS 2012 to 2016. 2021
Reply to "Simple Methods for Predicting Cardiovascular Readmission After a Heart Failure Hospitalization". 2021
Reply: To PMID 25772741. 2015
Statistical considerations in determination of ventricular volume from echocardiographic and angiographic data. 1978
The new cholesterol education imperative and some comments on niacin.. 81. 1998
Evolution of the exercise electrocardiogram.. 73. 1994
Meta-Analysis of Usefulness of Anticoagulation After Transcatheter Aortic Valve Implantation. 2017
Lipoprotein Metabolism and Inflammation in Patients With Psoriasis. 2016
Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy. 2009
Role of C-reactive protein in coronary risk reduction: focus on primary prevention. 2007
Role of depression and inflammation in incident coronary heart disease events. 2005
Impact of multiple risk factors on coronary artery disease: beyond total cholesterol. Introduction. 1998
The hypertriglyceridemias: risk and management. Introduction. 1991
Left ventricular compliance: mechanisms and clinical implications. 1976
Meta-Analysis of Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease. 2021
Meta-Analysis of Transradial vs Transfemoral Access for Percutaneous Coronary Intervention in Patients With ST Elevation Myocardial Infarction. 2020
Meta-Analysis of Antithrombotic Strategies in Patients With Heart Failure With Reduced Ejection Fraction and Sinus Rhythm. 2020
Diagnosis of pulmonary embolism in the coronary care unit. 2009
Meta-analysis comparing reported frequency of atrial fibrillation after acute coronary syndromes in Asians versus whites. 2007
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes. 2007
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions. 2003
Evaluation of myocardial viability with contrast echocardiography. 2002
The role of contrast enhancement in echocardiographic assessment of left ventricular function. 2002
Relation of age to left ventricular function in clinically normal adults. 1998

VIVO Weill Cornell Medical College

The American journal of cardiology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)